SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-22-006449
Filing Date
2022-09-16
Accepted
2022-09-16 14:18:25
Documents
13
Period of Report
2022-09-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K isco_8k.htm   iXBRL 8-K 32402
2 PROMISSORY NOTE isco_ex1001.htm EX-10.1 13524
  Complete submission text file 0001683168-22-006449.txt   215896

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE isco-20220915.xsd EX-101.SCH 3266
4 XBRL LABEL FILE isco-20220915_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE isco-20220915_pre.xml EX-101.PRE 22385
7 EXTRACTED XBRL INSTANCE DOCUMENT isco_8k_htm.xml XML 3182
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51891 | Film No.: 221247803
SIC: 2834 Pharmaceutical Preparations